Høeg fired in latest FDA shakeup; 20 people die after taking Amgen drug

The agency has once again shuffled the leadership for two top drug review offices. Elsewhere, Parabilis partnered with Regeneron and an obesity pill is headed toward an approval in China.

Raccontata dabiopharmadive.com